European Neuropsychopharmacology
Publisher: Elsevier · ISSN 0924-977X · 27 articles
- Age and sex related differences on genotype stratified CYP450 mediated metabolism rate in healthy populations; a systematic review
- Editorial Board
- Viewing reproductive psychiatry through a three-patient framework
- Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report
- Psychedelics and suicidality: A double-edged sword - risks, mechanisms, and moving forward
- Nutraceuticals and phytoceuticals in the treatment of bipolar disorder: A systematic review and network meta-analysis
- Global patterns of clozapine prescribing: An international comparison of prescribing indications across 15 regions
- Genetic architecture of externalizing and internalizing traits in the general population and its link to psychiatric conditions and well-being: a multivariate approach
- Long-term outcomes of childhood ADHD stimulant use trajectories
- EEG resting-state gamma power as a potential biomarker of excitation / inhibition imbalance in autism: Evidence from the Autism Biomarkers Consortium for Clinical Trials
- Social cognitive impairment across the bipolar disorder continuum: A comparative study of high-risk, first-episode, and chronic groups
- From real-world experience to precision prescribing of antidepressants: a machine-learning analysis of clinicians’ treatment choices
- Association of plasmatic lipids and suicidal ideation in bipolar disorders: a FACE-BD cohort study
- Cognitive reserve beyond ageing and dementia: A framework for early psychosis prevention and intervention
- Prevalence and correlates of problematic social media use in Chinese adolescent psychiatric patients in Hong Kong
- Corrigendum to “T70. Genetics of treatment resistant depression in Pakistan; update from the DIVERGE study” [European Neuropsychopharmacology 87, Supplement 1 (2024) 191]
- Erratum to “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study” [European Neuropsychopharmacology 107 (2026) 112801]
- To smoke or not to smoke: smoking among people with depression or bipolar disorder
- Targeting neuroinflammation in neuropsychiatric disorders: The role of NLRP3 inflammasome signalling
- On the research on youth mental health: A scientometric analysis across mental disorders
- Prevalence and outcomes of co-occurring mental/physical comorbidities and substance use disorders: An atlas umbrella review including 156 systematic reviews with meta-analysis
- Efficacy and safety of GLP-1 receptor agonists in patients with schizophrenia spectrum disorders treated with antipsychotics: a systematic review and meta-analysis
- Beyond scales: Artificial intelligence, language, and behavior in suicide risk modeling-a narrative review
- Predicting cognitive-behavioral therapy outcomes in obsessive-compulsive disorder from inhibitory control neural activity: A mega-analysis and machine learning study from the ENIGMA-OCD consortium
- Targeting affective cognition during pregnancy to prevent postpartum depression: a randomized controlled trial with parity-specific effects
- Clinical correlates of complete versus partial remission in major depressive disorder: an exploratory analysis of three cohorts
- Are negative findings gaining ground at ECNP congresses? A 10-year analysis